Brand-name · Novo Nordisk
Wegovy Oral
Brand-name oral semaglutide tablets made by Novo Nordisk, taken once a day.

Price
From $609 every 28 days
Starter: $609 every 28 days for 3 payments, or $1,399 upfront for 3 months. Maintenance: $689 every 28 days for 3 payments, or $1,849 upfront for 3 months. Includes your first clinician visit.
Your card is authorized at checkout and charged only after a clinician reviews your answers. If treatment isn’t approved, you pay only the consultation fee. Cancellation & refunds
What it is
Wegovy tablets are the brand-name, FDA-approved oral form of semaglutide, a GLP-1 receptor agonist made by Novo Nordisk, for chronic weight management alongside a reduced-calorie diet and more physical activity.
FDA-approved for chronic weight management.
How it’s used
A tablet taken once a day, with specific timing around food and water that your clinician and pharmacist will explain. Your clinician decides whether it is appropriate for you.
Forms: Daily tablet
- Starter and maintenance plans
Before you start
- Requires a clinician evaluation to confirm eligibility.
- Not for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Your clinician will review your health history, current medications and possible side effects.
Wegovy is a registered trademark of Novo Nordisk. Zepbound, Mounjaro and Foundayo are trademarks of Eli Lilly and Company. Eve’s Sisters is not affiliated with or endorsed by either company. Brand-name medications are dispensed by licensed pharmacies only when a licensed provider prescribes them.
Prescription weight management requires a clinician evaluation to confirm eligibility. Programs are provider-supervised and used alongside nutrition and activity changes. Individual experiences vary.
Prices apply outside North Dakota and Ohio. This page is general information, not medical advice. Talk with a licensed clinician about your own health.
